PCM
PJP icon

Pointe Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Pointe Capital Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-14,920
Closed -$836K – 208
2016
Q4 		$836K Buy
+14,920
New +$859K 0.48% 48

Other funds holding PJP

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Pointe Capital Management's PJP Position: Q1 2017 in Review

Pointe Capital Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2017, closing a stake of 14,920 shares — an estimated $836K sold.

Pointe Capital Management first reported a position in PJP in Q4 2016 and held it in 1 quarter. The position peaked at $836K in Q4 2016. 96 funds tracked by Wall St. Rank hold PJP as of Q1 2017.

  • Pointe Capital Management reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2017 after selling out during the quarter.
  • Pointe Capital Management sold 14,920 Invesco Pharmaceuticals ETF shares in Q1 2017, an estimated $836K.
  • Pointe Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2016 and held it in 1 quarter.
  • Pointe Capital Management's Invesco Pharmaceuticals ETF position peaked at $836K in Q4 2016.
  • 96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2017.

Based on Pointe Capital Management's 13F filing for Q1 2017, filed 25 May 2017.